Icon

BLENOXANE (nda050443)- (EQ 15 UNITS BASE/VIAL,EQ 30 UNITS BASE/VIAL)

BLEOMYCIN SULFATE BRISTOL MYERS SQUIBB
EQ 15 UNITS BASE/VIAL,EQ 30 UNITS BASE/VIAL
No No
Expired Expired
None None
None No
BLENOXANE should be considered a palliative treatment. It has been shown to be useful in the management of the following neoplasms either as a single agent or in proven combinations with other approved chemotherapeutic agents: * Squamous Cell Carcinoma - Head and neck (including mouth, tongue, tonsil, nasopharynx, oropharynx, sinus, palate, lip, buccal mucosa, gingivae, epiglottis, skin, larynx), penis, cervix, and vulva. The response to BLENOXANE is poorer in patients with previously irradiated head and neck cancer. * Lymphomas - Hodgkin’s disease, non-Hodgkin’s lymphoma. * Testicular Carcinoma - Embryonal cell, choriocarcinoma, and teratocarcinoma. * BLENOXANE has also been shown to be useful in the management of: * Malignant Pleural Effusion - BLENOXANE is effective as a sclerosing agent for the treatment of malignant pleural effusion and prevention of recurrent pleural effusions.
5 0 5
Total Other Developers None
Drugs with Suitability No
EQ 15 UNITS BASE/VIAL ** ** - - -
EQ 30 UNITS BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ***** ******* ******** ******* ******* *********** **** **.*, *******, ******* ******** ****, ******* ***** *******, ******* ******, ****** ******, *********, ******* ******, ***** (***) ***
****** ***** ********** **** ********* *********** ************ **, **********, ***** ****** *****, ******* (***) ***
****** ********* **** *** ********* **** ***, *** *********** **** *. **** ****** **** ***** ********* ******, ******* ****, ******** (**) *****, ****** ****** (***) ***
****** ******** ****** *************** **., ***. *********** **.*-* ***** ****, ******* **-**** ************* ****** ****, *******, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.